ClearBridge Investments’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,664,147
Closed -$28.3M 738
2022
Q3
$28.3M Buy
1,664,147
+7,675
+0.5% +$165K 0.03% 390
2022
Q2
$35.6M Buy
1,656,472
+2,978
+0.2% +$82.6K 0.03% 374
2022
Q1
$61.2M Buy
1,653,494
+11,784
+0.7% +$459K 0.05% 318
2021
Q4
$74.7M Sell
1,641,710
-3,474
-0.2% -$181K 0.05% 291
2021
Q3
$104M Sell
1,645,184
-8,375
-0.5% -$638K 0.07% 229
2021
Q2
$151M Buy
1,653,559
+145,175
+10% +$11.5M 0.11% 181
2021
Q1
$103M Buy
1,508,384
+430,407
+40% +$33.4M 0.08% 215
2020
Q4
$78.1M Buy
1,077,977
+442,692
+70% +$25.7M 0.06% 245
2020
Q3
$24.1M Buy
+635,285
New +$21.4M 0.02% 392

Other funds holding CDNA

ClearBridge Investments's CDNA Position: Q4 2022 in Review

ClearBridge Investments sold out of CareDx (CDNA) in Q4 2022, closing a stake of 1,664,147 shares — an estimated $28.3M sold.

ClearBridge Investments first reported a position in CDNA in Q3 2020 and held it in 9 quarters. The position peaked at $151M in Q2 2021. 168 funds tracked by Wall St. Rank hold CDNA as of Q4 2022.

  • ClearBridge Investments reported no remaining CareDx position as of Q4 2022 after selling out during the quarter.
  • ClearBridge Investments sold 1,664,147 CareDx shares in Q4 2022, an estimated $28.3M.
  • ClearBridge Investments first reported a position in CareDx in Q3 2020 and held it in 9 quarters.
  • ClearBridge Investments's CareDx position peaked at $151M in Q2 2021.
  • 168 funds tracked by Wall St. Rank held CareDx as of Q4 2022.

Based on ClearBridge Investments's 13F filing for Q4 2022, filed 10 Feb 2023.